ER Pharmatech Co.,LTD

Neratinib

• Category :

  Pharmaceuticals and Biochemicals

• Synonyms :

  (2E)-N-[4-[[3-chloro-4-[(pyridin-2-yl)methoxy]phenyl]amino]-3-cyano-7-ethoxyquinolin-6-yl]-4-(dimethylamino)but-2-enamide;(2E)-N-(4-{[3-chloro-4-(pyridin-2-ylmethoxy)phenyl]amino}-3-cyano-7-ethoxyquinolin-6-yl)-4-(dimethylamino)but-2-enamide;HKI-272;

• CAS NO :

  698387-09-6

• EC NO :

• Molecular Formula :

  C₃₀H₂₉ClN₆O₃

• Molecular Weight :

  557.0427

• Main Specifications :

  99%

• InChI :

  InChI=1/C30H29ClN6O3/c1-4-39-28-16-25-23(15-26(28)36-29(38)9-7-13-37(2)3)30(20(17-32)18-34-25)35-21-10-11-27(24(31)14-21)40-19-22-8-5-6-12-33-22/h5-12,14-16,18H,4,13,19H2,1-3H3,(H,34,35)(H,36,38)/b9-7+

• Packing :

  As customer request

• Product description :

  Product Name: Neratinib Synonyms: nevatinib;(2e)-n-(4-((3-chloro-4-((pyridin-2-yl)Methoxy)phenyl)aMino)-3-cyano-7-ethoxyquinolin-6-yl)-4-(diMethylaMino)but-2-enaMide neratinib CAS: 698387-09-6 MF: C30H29ClN6O3 MW: 557.04266 EINECS: 811-237-1 Density: 1.33 Form: Off-white solid. Uses: An oral, irreversible dual EGFR/HER2 inhibitor for breast and non-small cell lung cancer. Antitumor agent

• Uses :

  An oral, irreversible dual EGFR/HER2 inhibitor for breast and non-small cell lung cancer. Antitumor agent

• Molecular Structure :